Pliant Therapeutics financials at a glance

+ Portfolio

The revenue of Pliant Therapeutics is reported as 0.00158 billion Dollars in the fiscal year 2023. The earnings were -2.75 Dollars per share in 2023, which was 6.46 higher than 2022. And about -0.11728 billion Dollars are reported as free cash flow in the financials of Pliant Therapeutics 2023. No dividends were paid to the shareholders of the Pliant Therapeutics stock NasdaqGS:PLRX in the financial year 2023.

$1.58M

Revenue

$-2.75

Earnings Per Share

100.00%

Gross Margin %

$-,126.00M

Free Cash Flow

Revenue

1.58

Earnings Per Share

-2.75

Gross Margin %

100.00

Free Cash Flow

-,126.00

Financials

Year	Year	TTM	2023	2022	2021	2020
Rev.	Revenue	N/A	$1.58M	$9.69M	$7.57M	$41.82M
GM %	Gross Margin %	100.00%	100.00%	100.00%	100.00%	100.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	-99.59%
EPS	Earnings Per Share	$-2.78	$-2.75	$-2.94	$-2.71	$-1.95
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	0	-0.00%
Sha.	Shares	N/AM	60.24M	58.94M	36.11M	35.74M
OCF	Operating Cash Flow	N/A	$-,116.36M	$-94.63M	$-75.44M	$0.00M
FCF	Free Cash Flow	N/A	$-,126.00M	$-96.39M	$-77.40M	$-38.80M
FCFS	Free Cash Flow Per Share	$-2.21	$-2.00	$-2.29	$-2.16	$-1.82

Pliant Therapeutics financials at a glance

Financials

Discover